Skip to main content
SpringerLink
Log in

Severe Infections of Soft Tissues (Including Fasciitis and Diabetic Foot Infections)

  • Chapter
Life-Threatening Dermatoses and Emergencies in Dermatology

  • 1307 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bernard P, Bedane C, Mounier M et al (1995) Bacterial dermo-hypodermatitis in adults. IncIDence and role of streptococcal etiology. Ann Dermatol Venereol 122: 495–500

    PubMed  CAS  Google Scholar 

  2. Bisno A, Stevens D (1996) Streptococcal infections of skin and soft tissuesN Engl J Med 334:240–245

    Article  PubMed  CAS  Google Scholar 

  3. Consensus conference: Management of erysipelas and necrotizing fasciitis (2001) Ann Dermatol Venereol 128:463–482

    Google Scholar 

  4. Bernard P, Bedane C, Mounier M et al (1989) Streptococcal cause of erysipelas and cellulitis in adults: a microbiologic study using a direct immunofluorescence technique. Arch Dermatol 125:779–782

    Article  PubMed  CAS  Google Scholar 

  5. Leppard BJ, Seal DV, Colman G (1985) The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas. Br J Dermatol 112:559–567

    Article  PubMed  CAS  Google Scholar 

  6. Goettsch WG, Bouwes Bavinck JN, Herings RMC (2006) Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol 20:834–839

    PubMed  CAS  Google Scholar 

  7. Dupuy A, Benchikhi H, Roujeau JC et al (1999) Risk factors for erysipelas of the leg (cellulitis): case-control study. Br Med J 318:1591–1594

    CAS  Google Scholar 

  8. Roujeau JC, Paul C et al (2004) Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case control study. Dermatology 209:301–307

    Article  PubMed  Google Scholar 

  9. Ronnen M, Suster S, Schewach-Millet et al (1985) Erysipelas: changing faces. Int J Dermatol 24:169–172

    PubMed  CAS  Google Scholar 

  10. Crickx B, Chevron F, Sigal-Nahum M et al (1991) Erysipelas: epIDemiological, clinical and therapeutic data (111 cases). Ann Dermatol Venereol 118:11–16

    PubMed  CAS  Google Scholar 

  11. Leclerc S, Teixeira A Mahé E et al (2007) Recurrent erysipelas: 47 cases. Dermatology 214:52–57

    Article  PubMed  CAS  Google Scholar 

  12. Vignes S, Dupuy A (2006) Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibio-therapy: a retrospective cohort study. J Eur Acad Dermatol 20:818–822

    CAS  Google Scholar 

  13. Coste N, Perceau G, Leone J et al (2004) Osteoarticular complications of erysipelas. J Am Acad Dermatol 50:203–209

    Article  PubMed  Google Scholar 

  14. Kopp M, Bernard P, Schmit JL (2001) [Dealing with bacterial hypodermal infection in general practice: an inquiry and a prospective study]. Ann Dermatol Venereol 128: 338–344

    PubMed  CAS  Google Scholar 

  15. Musette P, Benichou J, Noblesse I et al (2004) Determinants of severity for superficial cellutitis (erysipelas) of the leg: a retrospective study. Eur J Intern Med 15:446–450

    Article  PubMed  Google Scholar 

  16. Jegou J, Hansmann Y, Chalot F et al (2002) Hospitalization criteria for erysipelas: prospective study in 145 cases. Ann Dermatol Venereol 129:375–379

    PubMed  CAS  Google Scholar 

  17. Stevens DL, Bisno AL, Chambers HF et al (2005). Practice guIDelines for the management of skin and soft tissue infections. Clin Infect Dis 41:1373–1406

    Article  PubMed  Google Scholar 

  18. Jorup-Rönström C, Britton C, Gavlevik A et al (1984) The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas. Infection 12:390–394

    Article  PubMed  Google Scholar 

  19. Bernard P, ChosIDow O, Vaillant L (2002) Oral pristinamy-cin versus standard penicillin regimen to treat erysipelas in adult patients: randomised, non-inferiority, open trial. Br Med J 325:864–866

    Article  CAS  Google Scholar 

  20. Estines O, Coste N, Perceau G et al (2003) [Haemorrhagic cellulitis: three cases]. Ann Dermatol Venereol 130:523–526

    PubMed  CAS  Google Scholar 

  21. Heng MC, Khoo M, Cooperman A, Fallon-Friedlander S (1994) Haemorragic cellulitis: a syndrome associated with tumour necrosis factor-alpha. Br J Dermatol 130:65–74

    Article  PubMed  CAS  Google Scholar 

  22. Moran GJ, Krishnadasan A, Gorwitz RJ et al (2006) Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666–674

    Article  PubMed  CAS  Google Scholar 

  23. Gabillot-Carré M, Roujeau JC (2007) Acute bacterial skin infections and cellulitis. Curr Opin Infect Dis 20:118–123

    Article  PubMed  Google Scholar 

  24. Phillips S, MacDougall C, Holdford DA et al (2007) Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus. Ann Pharmacother 41:13–20

    PubMed  CAS  Google Scholar 

  25. Hasham S, Matteuci P, Stanley PR et al (2005) Necrotising fasciitis. Br Med J 330:830–833

    Article  Google Scholar 

  26. Liu YM, Chi CY, Ho MW et al (2005) Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect 38:430–435

    PubMed  Google Scholar 

  27. Miller LG, Perdreau-Remington F, Rieg G et al (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:1445–1453

    Article  PubMed  CAS  Google Scholar 

  28. Kaul R, McGeer A, Low DE et al (1997) Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario group A Streptococcal study. Am J Med 103:18–24

    Article  PubMed  CAS  Google Scholar 

  29. Zerr DM, Alexander ER, Duchin JS et al (1999) A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 103:783–790

    Article  PubMed  CAS  Google Scholar 

  30. Aronoff DM, Bloch KC (2003) Assessing the relationship between the use of nonsteroIDal anti-inflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine (Baltimore) 82:225–235

    Article  CAS  Google Scholar 

  31. Revelon G, Rhamouni A, Jazaerli X et al (1999) Acute swelling of the limbs: magnetic resonance pictorial review of fascial and muscle signal changes. Eur J Radiol 30:11–21

    Article  PubMed  CAS  Google Scholar 

  32. Saiag P, LeBreton C, Pavlovic M et al (1994) Magnetic resonance imaging in adults presenting with severe acute infectious cellulitis. Arch Dermatol 130:1150–1158

    Article  PubMed  CAS  Google Scholar 

  33. Golger A, Ching S, Goldsmith CH et al (2007) Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg 119:1803–1807

    Article  PubMed  CAS  Google Scholar 

  34. Voros D, Pissiotis C, Antoniou S et al (1993) Role of early and extensive surgery in the treatment of severe necrotizing soft tissue infection. Br J Surg. 80:1190–1191

    Article  PubMed  CAS  Google Scholar 

  35. Société de Pathologie Infectieuse de Langue Française (2007) Short text. Management of diabetic foot infections. Med Mal Infect 37:1–25

    Google Scholar 

  36. International Working Group on the Diabetic Foot (2003) International consensus on the diabetic foot [CD-ROM]. In: International Diabetes Foundation; Brussels. http// www.iwgdf.org

    Google Scholar 

  37. Lipsky BA, Berendt AR, Embil J, De Lalla F (2004) Diagnosing and treating diabetic foot infections. Diab Metab Res Rev 20:s56–s64

    Article  Google Scholar 

  38. Lavery A, Harkless LB, Felder-Johnsn K, Mundine S (1994) Bacterial pathogens in infected puncture wounds in adults with diabetes. J Foot Ankle Surg 33:91–97

    PubMed  CAS  Google Scholar 

  39. El-Tahawy A (2000) Bacteriology of diabetic foot. Saudi Med J 213:44–47

    Google Scholar 

  40. Dang CN, Prasad YDM, Boulton AJ, Jude EB (2003) Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diab Med 20: 159–161

    Article  CAS  Google Scholar 

  41. Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 336:1719–1724

    Article  Google Scholar 

  42. Lavery LA, Armstrong DG, Wunderlich RP et al (2006) Risk factors for foot infections in indivIDuals with diabetes. Diab Care 29:1288–1293

    Article  Google Scholar 

  43. Capriotti G, Chianelli M, Signore A (2006) Nuclear medicine imaging of diabetic foot infection: results of meta-anal-ysis. Nucl Med Commun 27:757–764

    Article  PubMed  Google Scholar 

  44. El-Maghraby TA, Moustafa HM, Pauwels EK (2006) Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. Q J Nucl Med Mol Imag 50:167–192

    CAS  Google Scholar 

  45. Ertrugul MB, Baktiroglu S, Salman S et al (2006) The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diab Med 23:649–653

    Article  Google Scholar 

  46. Kumar V (2005) Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging. Q J Nucl Med Mol Imaging 49:325–338

    PubMed  CAS  Google Scholar 

  47. Armstrong DG, Lavery LA, Harkless LB (1998) The contribution of depth, infection and ischemia to risk of amputation. Diab Care 21:855–858

    Article  CAS  Google Scholar 

  48. Rao N, Lipsky BA (2007) Optimising antimicrobial therapy in diabetic foot infections. Drugs 67:195–214

    Article  PubMed  CAS  Google Scholar 

  49. Lipsky BA, Sheehan P, Armstrong DG et al (2007) Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J 4:30–38

    Article  PubMed  Google Scholar 

  50. Nelson EA, O'Meara S, Golder S et al (2006) Systematic review of antimicrobial treatments for diabetic foot ulcers. Diab Med 23:348–359

    Article  CAS  Google Scholar 

  51. Pisky A, Armstrong DG, Citron DM et al (2005) Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trialLancet 366:1695–1703

    Article  CAS  Google Scholar 

  52. Cruciani M, Libsky BA, Mengoli C et al (2005) Are granu-locyte colony-stimulating factors beneficial in treating diabetic foot infections? Diab Care 28:454–460

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Robert Debré Hospital, Reimscedex, 51092, France

    Philippe Bernard

Authors
  1. Philippe Bernard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Service de Dermatologie, Centre hospitalier universitaire Henri Mondor, 51 av du Maréchal de Lattre de Tassigny, Créteil, 94010, France

    Jean Revuz  & Laurence Valeyrie-Allanore  & 

  2. Université Paris XII Service de Dermatologie, Centre hospitalier universitaire Henri Mondor, 51 av du Maréchal de Lattre de Tassigny, Créteil, 94010, France

    Jean-Claude Roujeau

  3. Department of Dermatology, Cedars Medical Center, 1400 NW 12 Avenue 6th South, Miami, FL, 33136, USA

    Francisco A. Kerdel

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bernard, P. (2009). Severe Infections of Soft Tissues (Including Fasciitis and Diabetic Foot Infections). In: Revuz, J., Roujeau, JC., Kerdel, F.A., Valeyrie-Allanore, L. (eds) Life-Threatening Dermatoses and Emergencies in Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79339-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79339-7_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79338-0

  • Online ISBN: 978-3-540-79339-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation